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background:  Subcutaneous implantable cardioverter defibrillator (S-ICD) offers potential benefits for hemodialysis (HD) patients by 
preserving vascular access sites and reducing the risk of blood stream infections. However, HD patients were excluded from initial S-ICD 
trials and limited data are available regarding outcomes in these patients.
Methods:  We collected data regarding demographics, safety, efficacy and long-term follow-up of all patients implanted with S-ICD at our 
center between October 2012 and June 2014. We compared short- and long-term outcomes between HD and non-HD patients.
results:  S-ICD was implanted in 61 patients-13 were on HD and 48 were not on HD. There was no significant difference in baseline 
demographics. HD patients had more S-ICD implants for secondary prevention (p value 0.005). They had more procedural complications (p 
value 0.007), longer inpatient stay (3.9 vs. 1.4 days, p value 0.001) and increased inpatient mortality (p value 0.006). After a median follow-up 
of 160 days, HD patients received more appropriate shocks (p value 0.007). HD patients also had increased all-cause mortality during follow-
up (Figure 1). Blood stream infection was not seen in any patient. Pocket infection was seen in 4 patients and none of them were on HD.
Conclusion:  Patients on HD, who are implanted with S-ICD, have worse short- and long-term outcomes, compared with non-HD patients. 
However, S-ICD implantation is associated with reduced risk of infection, especially in HD patients.
